Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Silence Therapeutics (SLN) Accumulated Depreciation & Amortization (2023 - 2025)

Silence Therapeutics' Accumulated Depreciation & Amortization history spans 2 years, with the latest figure at $4.5 million for Q4 2024.

  • For Q4 2024, Accumulated Depreciation & Amortization rose 8.1% year-over-year to $4.5 million; the TTM value through Dec 2024 reached $4.5 million, up 8.1%, while the annual FY2024 figure was $4.5 million, 8.23% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2024 was $4.5 million at Silence Therapeutics, up from $4.2 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.5 million in Q4 2024 and bottomed at $4.2 million in Q4 2023.